U.S. defense companies, until recently one of the main beneficiaries of market uncertainty and fear, are retreating from record valuations today before the open. Losing stocks include General Dynamics (GD.US) Lockheed Martin (LMT.US), Northrop Grumman (NOC.US) Raytheon (RTX.US) and Huntington Ingalls (HII.US):
- The reasons for the declines are likely to be comments by Kremlin spokesman Dmitry Peskov, who indicated that 'the goals of the special operation in Ukraine can be achieved not only through military means but also through negotiations' and China's Foreign Minister Lijan Zhao's confirmed meeting between Biden and Xi Jinping at the G20 summit. Zhao stressed that China hopes to cooperate with the Americans and set a new path in mutual diplomatic relations. The Ukrainian army reported the recapture of Kherson and the push of Russia to the other side of the Dnipro River.
An updated map indicating Russian maneuvers and territorial control in Ukraine. The heaviest fighting continues on the southern (Kherson) and northeastern (Lugansk and Donetsk) fronts. Source: ISW
Huntington Ingalls (HII.US) shares, D1 interval. Huntington is one of the main suppliers of warships to the US military. The stock is losing nearly 3% today before the open indicating an opening at the 50-session moving average, which runs around $236 and has so far marked an upward trend line. Source: xStation5
TSMC Earnings Preview: Will the Key Semiconductor Supplier Surprise the Market?
US Open: American Indices Rally on Anticipated End of Fed Balance Sheet Reduction
Bank of America, Wells Fargo, and Morgan Stanley: Q3 2025 Earnings Overview
Abbott reports no surprises in Q3, but tariff risks and lowered forecasts drag the share price downđź’ˇ
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
